Targeting mRNA-coding genes in prostate cancer using CRISPR/Cas9 technology - special focus on androgen receptor signaling
Favorite
Share
More Options
Fullscreen
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
